{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:08:34Z","timestamp":1788185314569,"version":"build-2803163510"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Activated cytotoxic T cells (CTLs) recognize the auto-antigens presented on hematopoietic stem\/progenitor cells (HSPCs) through class I human leukocyte antigen (HLA) molecules and play an important role in the immune pathogenesis of aplastic anemia (AA). Previous reports demonstrated that HLA was related to the disease susceptibility and response to immunosuppressive therapy (IST) in AA patients. Recent studies have indicated that specific HLA allele deletions, which helped AA patients to evade CTL-driven autoimmune responses and escape from immune surveillance, may lead to high-risk clonal evolution. Therefore, HLA genotyping has a particular predictive value for the response to IST and the risk of clonal evolution. However, there are limited studies on this topic in the Chinese population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To explore the value of HLA genotyping in Chinese patients with AA, 95 AA patients treated with IST were retrospectively investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The alleles HLA-B*15:18 and HLA-C*04:01 were associated with a superior long-term response to IST (P = 0.025; P = 0.027, respectively), while the allele HLA-B*40:01 indicated an inferior result (P = 0.02). The allele HLA-A*01:01 and HLA-B*54:01 were associated with high-risk clonal evolution (P = 0.032; P = 0.01, respectively), and the former had a higher frequency in very severe AA (VSAA) patients than that in severe AA (SAA) patients (12.7% vs 0%, P = 0.02). The HLA-DQ*03:03 and HLA-DR*09:01 alleles were associated with high-risk clonal evolution and poor long-term survival in patients aged \u226540 years. Such patients may be recommended for early allogeneic hematopoietic stem cell transplantation rather than the routine IST treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>HLA genotype has crucial value in predicting the outcome of IST and long-term survival in AA patients, and thus may assist an individualized treatment strategy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1056381","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T08:16:09Z","timestamp":1675066569000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemia"],"prefix":"10.3389","volume":"14","author":[{"given":"Lingyun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meili","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neng","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-010777","article-title":"Current concepts in the pathophysiology and treatment of aplastic anemia","volume":"108","author":"Young","year":"2006","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15443","article-title":"Advances in understanding the pathogenesis of acquired aplastic anaemia","volume":"182","author":"Luzzatto","year":"2018","journal-title":"Br J Haematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66515-4","article-title":"Aplastic anemia","volume":"365","author":"Brodsky","year":"2005","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.6.1931","article-title":"Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO\/EBMT study on 100 patients","volume":"95","author":"Bacigalupo","year":"2000","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.12.4257.bloodjournal84124257","article-title":"Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia","volume":"84","author":"Nakao","year":"1994","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2014.06.011","article-title":"The polymorphisms of human leukocyte antigen loci may contribute to the susceptibility and severity of severe aplastic anemia in Chinese patients","volume":"75","author":"Wang","year":"2014","journal-title":"Hum Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.5.1570.h81702001570_1570_1574","article-title":"HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome","volume":"100","author":"Saunthararajah","year":"2002","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s0925-5710(97)00054-6","article-title":"HLA DR2: a predictive marker in response to cyclosporine therapy in aplastic anemia","volume":"66","author":"Ihan","year":"1997","journal-title":"Int J Hematol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.humimm.2009.10.002","article-title":"Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients","volume":"71","author":"Song","year":"2010","journal-title":"Hum Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v98.13.3513","article-title":"Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH\/aplastic anemia syndrome","volume":"98","author":"Maciejewski","year":"2001","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-365189","article-title":"Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia","volume":"118","author":"Katagiri","year":"2011","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017010918","article-title":"Somatic HLA mutations expose the role of class I-mediated autoimmunity in aplastic anemia and its clonal complications","volume":"1","author":"Babushok","year":"2017","journal-title":"Blood Adv"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012895","article-title":"HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia","volume":"138","author":"Zaimoku","year":"2021","journal-title":"Blood"},{"key":"B14","article-title":"The frequency of HLA class I alleles in Japanese patients with bone marrow failure","volume":"91","author":"Shichishima","year":"2006","journal-title":"Haematologica"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3109\/08820130903271415","article-title":"The frequency of HLA class I and II alleles in Pakistani patients with aplastic anemia","volume":"38","author":"Rehman","year":"2009","journal-title":"Immunol Invest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2020.07.001","article-title":"Association of HLA class II (-DRB1, -DQB1, -DPB1) alleles and haplotypes on susceptibility to aplastic anemia in northern Chinese han","volume":"81","author":"Qi","year":"2020","journal-title":"Hum Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm","article-title":"Susceptibility to aplastic anemia is associated with HLA-DRB1*1501 in an aboriginal population in sabah, Malaysia","volume":"72","author":"Dhaliwal","year":"2011","journal-title":"Hum Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2020.01.004","article-title":"Genome-wide association study identifies HLA-DPB1 as a significant risk factor for severe aplastic anemia","volume":"106","author":"Savage","year":"2020","journal-title":"Am J Hum Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V70.6.1718.1718","article-title":"Incidence of aplastic anemia: the relevance of diagnostic criteria. by the international agranulocytosis and aplastic anemia study","volume":"70","year":"1987","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198203183061105","article-title":"Aplastic anemia: pathogenesis, diagnosis, treatment, and prognosis","volume":"306","author":"Camitta","year":"1982","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07450.x","article-title":"Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia","volume":"144","author":"Scheinberg","year":"2009","journal-title":"Br J Haematol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-304071","article-title":"A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA working party of the European group for blood and marrow transplantation","volume":"117","author":"Tichelli","year":"2011","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-1140-9","article-title":"Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience","volume":"90","author":"Li","year":"2011","journal-title":"Ann Hematol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1182\/blood.2021012130","article-title":"Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study","volume":"139","author":"Patel","year":"2022","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1414799","article-title":"Somatic mutations and clonal hematopoiesis in aplastic anemia","volume":"373","author":"Yoshizato","year":"2015","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.120931","article-title":"Mutations of ASXL1 and TET2 in aplastic anemia","volume":"100","author":"Huang","year":"2015","journal-title":"Haematologica"},{"key":"B27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1182\/blood.2019000940","article-title":"Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria","volume":"136","author":"Sun","year":"2020","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v89.10.3691","article-title":"Isolation of a T-cell clone showing HLA-DRB1*0405-restricted cytotoxicity for hematopoietic cells in a patient with aplastic anemia","volume":"89","author":"Nakao","year":"1997","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.7.4159","article-title":"Minor antigen h60-mediated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T cells","volume":"178","author":"Chen","year":"2007","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16724-X","article-title":"In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing","volume":"364","author":"Risitano","year":"2004","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2015.10.002","article-title":"Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemia","volume":"209","author":"Betensky","year":"2016","journal-title":"Cancer Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-752378","article-title":"Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia","volume":"129","author":"Zaimoku","year":"2017","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.293825.x","article-title":"Response to immunosuppressive therapy and an HLA-DRBl allele in patients with aplastic anaemia: HLA-DRBl*1501 does not predict response to antithymocyte globulin","volume":"92","author":"Nakao","year":"1996","journal-title":"Br J Haematol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/MOH.0000000000000699","article-title":"The significance of CUX1 and chromosome 7 in myeloid malignancies","volume":"29","author":"Jotte","year":"2022","journal-title":"Curr Opin Hematol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1056381\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T08:16:12Z","timestamp":1675066572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1056381\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":34,"alternative-id":["10.3389\/fimmu.2023.1056381"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1056381","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,30]]},"article-number":"1056381"}}